367 related articles for article (PubMed ID: 6142304)
21. [Post-transplantation lymphomas and Epstein-Barr virus].
Caillard S; Heibel F; Benaicha M; Moulin B
Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
23. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
Nalesnik MA; Jaffe R; Starzl TE; Demetris AJ; Porter K; Burnham JA; Makowka L; Ho M; Locker J
Am J Pathol; 1988 Oct; 133(1):173-92. PubMed ID: 2845789
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
Dotti G; Fiocchi R; Motta T; Gamba A; Gotti E; Gridelli B; Borleri G; Manzoni C; Viero P; Remuzzi G; Barbui T; Rambaldi A
Transplantation; 2000 Mar; 69(5):827-33. PubMed ID: 10755535
[TBL] [Abstract][Full Text] [Related]
25. Multifocal aggressive lymphoma of the gastrointestinal tract in a renal transplant patient treated with cyclosporin A and prednisone.
Castro CJ; Klimo P; Worth A
Cancer; 1985 Apr; 55(8):1665-7. PubMed ID: 3884129
[TBL] [Abstract][Full Text] [Related]
26. Post-transplant lymphoproliferative disorders in a cohort of adult patients with a liver transplant from a reference hospital in Bogotá, Colombia.
Jurado LF; Gómez-Aldana A; Tapias M; Cáceres D; Vera A; López-Panqueva RDP; Andrade RE
Biomedica; 2020 Sep; 40(3):498-506. PubMed ID: 33030828
[TBL] [Abstract][Full Text] [Related]
27. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
[TBL] [Abstract][Full Text] [Related]
29. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
30. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
31. Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey.
Karakoyun M; Önen Ş; Baran M; Çakır M; Ömür Ecevit Ç; Kılıç M; Kantar M; Aksoylar S; Özgenç F; Aydoğdu S
Turk J Gastroenterol; 2018 Jan; 29(1):89-93. PubMed ID: 29391313
[TBL] [Abstract][Full Text] [Related]
32. Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Watts RG; Hilliard LM; Berkow RL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):622-6. PubMed ID: 12439033
[TBL] [Abstract][Full Text] [Related]
33. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation.
Pirsch JD; Stratta RJ; Sollinger HW; Hafez GR; D'Alessandro AM; Kalayoglu M; Belzer FO
Am J Med; 1989 Feb; 86(2):241-4. PubMed ID: 2536518
[No Abstract] [Full Text] [Related]
34. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
[TBL] [Abstract][Full Text] [Related]
35. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
Mentzer SJ; Perrine SP; Faller DV
Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
[TBL] [Abstract][Full Text] [Related]
36. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
[TBL] [Abstract][Full Text] [Related]
37. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
[TBL] [Abstract][Full Text] [Related]
38. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival after post-transplant lymphoproliferative disease in children.
Nathanson S; Debray D; Delarue A; Deschênes G
Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
